DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2019-12-11 for DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222 manufactured by Ethicon Inc..

Event Text Entries

[170939451] (b)(4). Attempts to obtain the following information have been made with no response to date. If further details are received at a later date a supplemental medwatch will be sent. What other type of medical / surgical treatment was provided to treat the reaction? What prep was used prior to, during or after prineo use? How many layers of adhesive were used over during application? Was a dressing placed over the incision? If so, what type of cover dressing used? Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? What is the physicians opinion of the contributing factors to the reaction? Was the patient exposed to similar products, such as artificial nails? Was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure? Current status of patient? Related adverse events captured in reports: 2210968-2019-90742. To date the device has not been returned. If the device or further details are received at a later date a supplemental medwatch will be sent.
Patient Sequence No: 1, Text Type: N, H10


[170939452] It was reported a patient underwent a bilateral anterior & lateral compartment fasciotomies on (b)(6) 2019 and topical skin adhesive was used. 2 weeks post op, reaction appeared. Patient removed dressing at home with warm water in the shower. Reporting a red rash under and around the edges of the adhesive. Prior to this patient reports no issues. Visited general practioner two days later as saw no improvement. General practioner commenced oral and topical steroids. Reaction improved. Oral steroids finished after 5 days. Patient continued on topical treatment. However no further improvement in wound area was reported, milder rash persisted. (b)(6) 2019 a new rash appeared on the patients thighs, progressing to 'welts' (b)(6) 2019. Pt still using topical steroid cream. Oral steroids started again on (b)(6) 2019 post ortho clinic visit. Clinic have recommended pt cease topical over this weekend to determine if unintentional steroid exposure to the thighs is causing the rash and welts. Patient booked to revisit clinic (b)(6) 2019 for follow-up review.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2019-90743
MDR Report Key9449727
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2019-12-11
Date of Report2019-11-21
Date of Event2019-11-08
Date Mfgr Received2019-12-12
Date Added to Maude2019-12-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.-SAN LORENZO PR
Manufacturer StreetROAD 183, KM. 8.3
Manufacturer CitySAN LORENZO
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE
Generic NameSURGICAL SEALANT
Product CodeOMD
Date Received2019-12-11
Catalog NumberCLR222
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 08876 US 08876


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-12-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.